PMID: 22638549
Dipasupil, MD Obesity, Lifestyle & Aesthetic Medicine Conclusion: The 2026 Verdict on Wegovy Wegovy 's arrival in the Philippines is a genuine inflection point for medical weight management
For weight management, NICE eligibility criteria include: Body Mass Index (BMI) 35 kg/m with at least one weight-related comorbidity (such as type 2 diabetes, hypertension, obstructive sleep apnoea, or cardiovascular disease), OR BMI 30 kg/m in certain circumstances, particularly for individuals with type 2 diabetes where weight loss would provide significant metabolic benefit Evidence of previous attempts at weight management through lifestyle interventions (dietary modification and increased physical activity) Commitment to ongoing lifestyle changes and regular monitoring For individuals of South Asian, Chinese, other Asian, Middle Eastern, Black African, or African-Caribbean family background , lower BMI thresholds may apply (typically 2.5 kg/m lower) due to increased cardiometabolic risk at lower body weights
after that date, the cash price will increase to $199 for the 4-mg dose
